Ozben Beste, Toprak Ahmet, Koc Mehmet, Sumerkan Mutlu, Tanrikulu Azra M, Papila-Topal Nurdan, Kefeli Utku S, Cincin Altug A, Baykan Oytun, Fak Ali S
Department of Cardiology, Marmara University School of Medicine, Istanbul, Turkey.
Nephron Clin Pract. 2009;112(3):c171-6. doi: 10.1159/000214213. Epub 2009 Apr 24.
BACKGROUND/AIMS: Atrial fibrillation (AF) is common among hemodialysis (HD) patients and is associated with high mortality. P wave dispersion (PWD) is a noninvasive electrocardiographic marker of paroxysmal AF. Our aim was to evaluate the effect of HD session on PWD.
Twenty-five patients (mean age 63 years, 10 males) with sinus rhythm and undergoing chronic HD treatment were included. Blood samples were drawn and 12-lead electrocardiograms were recorded immediately before HD session, at the 2nd hour during HD and at the end of the HD session. The difference between maximum and minimum P wave durations was calculated as PWD.
PWD significantly increased during HD sessions compared with predialysis values (41 +/- 12 vs. 21 +/- 10 ms, respectively, p < 0.001), then decreased to a value of 24 +/- 7 ms at the completion of HD, which was not significantly different from the predialysis values. PWD during HD was significantly correlated with predialysis systolic and diastolic blood pressure (r = 0.42, p = 0.037, and r = 0.59, p = 0.002, respectively) and predialysis serum potassium level (r = 0.44, p = 0.031). Linear regression model revealed that predialysis diastolic blood pressure (p = 0.002), predialysis serum potassium level (p = 0.037) and the amount of ultrafiltration (p = 0.048) were the significant predictors of prolonged PWD during HD.
PWD increases significantly during HD sessions. This may increase the risk of AF episodes during HD. High diastolic blood pressure and serum potassium level before HD and ultrafiltration amount may predict prolonged PWD during HD.
背景/目的:心房颤动(AF)在血液透析(HD)患者中很常见,且与高死亡率相关。P波离散度(PWD)是阵发性AF的一种无创心电图标志物。我们的目的是评估HD治疗过程对PWD的影响。
纳入25例(平均年龄63岁,男性10例)窦性心律且正在接受慢性HD治疗的患者。在HD治疗前、HD治疗第2小时以及HD治疗结束时采集血样并记录12导联心电图。计算最大和最小P波时限之间的差值作为PWD。
与透析前值相比,HD治疗期间PWD显著增加(分别为41±12 ms和21±10 ms,p<0.001),然后在HD结束时降至24±7 ms,与透析前值无显著差异。HD治疗期间的PWD与透析前收缩压和舒张压显著相关(分别为r = 0.42,p = 0.037,以及r = 0.59,p = 0.002)和透析前血清钾水平(r = 0.44,p = 0.031)。线性回归模型显示,透析前舒张压(p = 0.002)、透析前血清钾水平(p = 0.037)和超滤量(p = 0.048)是HD治疗期间PWD延长的显著预测因素。
HD治疗期间PWD显著增加。这可能会增加HD治疗期间AF发作的风险。HD治疗前的高舒张压、血清钾水平和超滤量可能预测HD治疗期间PWD延长。